Virus-encoded OX40L and CD40L improve tumor growth control of the PeptiCRAd cancer vaccine and induce robust infiltration of tumor-specific CD8+ effector T cells in a syngeneic mouse model of B16.OVA melanoma. This evidence concerns the gene CD8A and cancer.